Patient info Open main menu

Invita D3 5 600 IU soft capsules – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
5 600 IU
Contains active substance:

Patient leaflet - Invita D3 5 600 IU soft capsules

1. WHAT INVITA D3 IS AND WHAT IT IS USED FOR

InVita D3 contains vitamin D3 which regulates the uptake and metabolism of calcium as well as the incorporation of calcium in bone tissue.

InVita D3 is used to prevent and treat vitamin D3 deficiency in adults and adolescents.

Your doctor may prescribe InVita D3 as an adjunct to specific bone loss medication.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE INVITA D3

Do not take InVita D3:

  • if you are allergic to colecalciferol or any of the other ingredients of this medicine (listed in section 6).
  • if you have hypercalcaemia (increased levels of calcium in the blood) or hypercalciuria (increased levels of calcium in the urine).
  • if you have hypervitaminosis D (increased levels of vitamin D in the blood).
  • if you have kidney stones.

If any of the above applies to you, talk to your doctor or pharmacist before taking InVita D3.

Warnings and precautions

Talk to your doctor or pharmacist before taking InVita D3:

  • if you suffer from sarcoidosis (a special type of connective tissue disease that affects the lungs, skin and joints).
  • when using other drugs containing vitamin D.
  • if you have kidney problems or have had kidney stones.

Children

This medicine is not recommended for use in children under 12 years of age.

Other medicines and InVita D3

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, in particular any of the following:

  • Cholestyramine (used to treat high cholesterol).
  • Phenytoin or barbiturates (used to treat epilepsy).
  • Laxatives which contain paraffin oil.
  • Thiazide diuretics (to treat high blood pressure).
  • Glucocorticoids (to treat inflammation).
  • Cardiac glycosides (to treat heart conditions), e.g. digoxin.
  • Actinomycin (chemotherapy)
  • Imidazole (antifungal)
  • Orlistat (weight loss aid)

InVita D3 with food and drink

See section 3 “How to take InVita D3”.

Pregnancy and breast-feeding:

InVita D3 can be used up to 2 capsules a week during pregnancy, only if you have been diagnosed with vitamin D deficiency and following the advice of your doctor.

InVita D3 can be used during breastfeeding. Vitamin D3 passes over into breast milk. This should be considered when giving additional vitamin D to the breast-fed child.

Ask your doctor or pharmacist for advice before taking InVita D3 during pregnancy, if you are breast feeding or if you are planning to have a baby.

Driving and using machines

InVita D3 has no known effects on ability to drive or use machines.

Client : Consilient Health Ltd.

Project : Dec 2023

Item(s) : InVita D3 5,600 IU soft capsules

Size : 160 x 240 mm

Software : InDesign CC

FONTS

Helvetica Neue Lt Std

Globale

DESIGNED BY

Minty

PLEASE NOTE : PAPER COPIES ARE SUPPLIED AS A VISUAL REFERENCE ONLY. DO NOT MATCH FOR COLOUR

CONSILIENT CODE : P1656

InVita D3 contains Allura Red AC (E129) and Sunset Yellow FCF (E110)

InVita D3 5,600 IU soft capsules contain Allura Red AC (E129) and Sunset Yellow FCF (E110) which may cause allergic reactions.

If you are allergic to the above colouring agents, consult your doctor or pharmacist.

3. HOW TO TAKE INVITA D3

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The capsules should be swallowed whole with water. InVita D3 can be taken with or without food.

The recommended dose is: 1 capsule every week. The weekly dose shall not exceed 5 capsules. Use in children

InVita D3 5,600 IU capsules are not intended for use in children under 12 years of age. Other forms of this medicine maybe more suitable for children; ask your doctor or pharmacist.

If you take more InVita D3 than you should If you have taken more of this medicine than directed, or if a child accidentally has taken this medicine, please contact your doctor or emergency unit for judgement of the risk and advice.

The most common symptoms of overdose are: nausea, vomiting, excessive thirst, the production of large amounts of urine over 24 hours, constipation and dehydration, high levels of calcium in the blood (hypercalcaemia) and in the urine (hypercalciuria) shown by lab test.

If you forget to take InVita D3

Do not take a double dose to make up for a forgotten dose.

If you stop taking InVita D3

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking InVita D3 and seek immediate medical help if you experience symptoms of serious allergic reactions, such as:

  • swollen face, lips, tongue or throat
  • difficulty swallowing
  • hives and difficulty breathing

Uncommon (may affect up to 1 in 100 people): Hypercalcaemia (increased levels of serum calcium) and hypercalciuria (increased levels of urine calcium). Rare (may affect up to 1 in 1,000 people): Itching, rash (Pruritus/urticaria).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not

listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE INVITA D3

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after Exp. The expiry date refers to the last day of the month.

Do not store above 25°C. Store in the original packaging to protect from light. Shelf life after first opening is 2 months. Plastic bottle only: Shelf life after first opening is 2 months.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What InVita D3 contains

  • The active substance is colecalciferol (vitamin D3). Each soft capsule contains 0.14 mg colecalciferol corresponding to 5,600 IU vitamin D3.
  • The other ingredients are: all-rac-α-tocopherol (E307), medium chain triglycerides,glycerol (E422), gelatin (E441), Purified water, Opacode® White imprinting ink (consisting of: Shellac (E904), Titanium dioxide (E171), Ammonium hydroxide (E527), Propylene Glycol (E1520), N-butyl alcohol, Isopropyl alcohol and simethicone), Allura Red AC (E129) and Sunset Yellow FCF (E110).

What InVita D3 looks like and contents of the pack InVita D3 5,600 IU is a red, oval-shaped, soft capsule. It contains a slightly yellow oily liquid. Each capsule has “5.6” printed in white ink.

Each carton contains 4 or 12 capsules packed in blisters or 250 capsules packed in a plastic bottle.

Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Consilient Health Limited,

Floor 3, Block 3, Miesian Plaza,

Dublin 2, D02 Y754, Ireland.

Manufacturer:

Consilient Health (UK) Ltd.,

1 Church Road, Richmond, TW9 2QE,

United Kingdom.

Consilient Health Limited,

Block 2A Richview Office Park, Clonskeagh, Dublin 14, D14 Y0A5, Ireland

This leaflet was last revised in 01/2024.

P1656

200024564

Client : Consilient Health Ltd.

Project : Dec 2023

Item(s) : InVita D3 5,600 IU soft capsules

Size : 160 x 240 mm

Software : InDesign CC

FONTS

Helvetica Neue Lt Std

Globale

DESIGNED BY

Minty

PLEASE NOTE : PAPER COPIES ARE SUPPLIED AS A VISUAL REFERENCE ONLY. DO NOT MATCH FOR COLOUR

CONSILIENT CODE : P1656

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 24837/0077

Last revision stated in the text: January 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Invita D3 5 600 IU soft capsules

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Colecalciferol
Strength 5 600 IU
Pharmaceutical form Oral capsule
Red, oval-shaped, soft capsule. It contains a slightly yellow oily liquid. Each capsule has “5.6” printed in white ink. Capsule dimensions are 10.6mm x 7mm.
How is it taken Oral
Excipients all-rac-α-tocopherol (E307), Medium Chain Triglycerides, Glycerol (E422), Gelatine (E441), Allura Red AC (E129), Sunset Yellow FCF (E110), Purified water, Opacode® White imprinting ink, Shellac (E904), Titanium dioxide (E171), Simethicone, Ammonium hydroxide (E527), Propylene Glycol (E1520), N-butyl alcohol, Isopropyl alcohol
Pack sizes 4 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 30 months
Storage Do not store above 25°C.
Store in the original package in order to protect from light.
Shelf life after first opening is 2 months.
Drug group (ATC) Vitamin D and analogues, colecalciferol
  1. A Alimentary tract and metabolism drugs
    1. A11 Vitamins
      1. A11C Vitamin A and D, incl. combinations of the two
        1. A11CC Vitamin D and analogues
          1. A11CC05 colecalciferol
Marketing authorisation PL 24837/0077 (first authorised 30 August 2016)
Marketing authorisation holder Consilient Health Limited
Codes GTIN 5391512453251 · BNF 09060400

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.